Structure of PDB 5kz0 Chain A Binding Site BS01 |
|
|
Global view | Local view | Structure summary |
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 5kz0 Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations. |
Resolution | 2.3 Å |
Binding residue (original residue number in PDB) | L1122 H1124 G1125 V1130 A1148 M1199 G1202 L1256 G1269 D1270 |
Binding residue (residue number reindexed from 1) | L30 H32 G33 V38 A48 M99 G102 L156 G169 D170 |
Annotation score | 1 |
Binding affinity | MOAD: Ki=22nM PDBbind-CN: -logKd/Ki=7.66,Ki=22nM BindingDB: Ki=22nM |
|
|
|
|
|